Prana Biotechnology Presents to US Investors at 34th Cowen Healthcare Conference March 4, 2014August 16, 2022
FDA Approval to Commence Huntington’s Disease Clinical Trial Using Prana’s PBT2: Huntington Study Group appointed to coordinate the trial and start recruitment July 17, 2013August 16, 2022
Alterity Therapeutics to Participate in the Benchmark Company Healthcare House Call Conference May 26, 2022May 23, 2023
